News
With a 5.0-star rating on Google based on over 250 reviews, Movement Room is frequently recommended as one of the top choices ...
CEPI and POP BIO are committed to enabling equitable access to the outputs of their partnership, in line with CEPI’s ...
The Celcuity management team will host a webcast/conference call on Monday, July 28, 2025 at 8:00 a.m. ET to discuss the topline results from the Phase 3 VIKTORIA-1 trial. Those who would like to ...
Brent Morrison, CFA, Chairman and Chief Executive Officer of Regional, stated, “Regional is pleased that ISS concluded that support for this transaction was warranted. Regional is even more pleased ...
Nick Vincent Joins Easy Environmental Solutions as Sales Operations Manager; Digital Utilities Ventures, Inc. (OTC: DUTV), ...
The Company intends to use the net proceeds from the Offering to pay $1,500,000 for marketing and advertising services to be provided by IR Agency LLC, $1,000,000 to fund the initial milestone payment ...
Liminatus is working in close coordination with experienced legal, financial, and regulatory advisors to determine the optimal structure, governance, and compliance framework for the proposed ...
Slated to open in mid-2026, the 60,000 square-foot Class-A industrial facility will significantly expand Nelipak’s regional capacity and capabilities. The new site will be ISO 13485 certified and ...
Results show biopsy-proven resolution of BK polyomavirus nephropathy in kidney transplant recipients No safety or tolerability concerns were observed Supports progression into Phase III development ...
Plant-based focus and clarity in every drop Built for people seeking clarity in high-performance environments, the Lives ...
Fairhaven Health has developed a highly curated line of multivitamins tailored to each stage of a woman’s life — paired with ...
PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results